Return to search

Vitreo Retinal Raises Series A

Vitreo Retinal Technologies Inc., an Irvine, Calif.-based developer of diganistic and therapeutic systems for the treatment of serious ocular diseases, has raised nearly $12 million in Series A funding led by De Novo Ventures, according to a regulatory filing. The deal included around $9.35 million in preferred stock, and $2.6 million worth of warrants.